Vor Biopharma Inc.
VOR
$0.59
-$0.044-6.94%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 27.88M | 29.14M | 30.15M | 31.22M | 31.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 121.19M | 118.00M | 124.80M | 127.94M | 126.04M |
| Operating Income | -121.19M | -118.00M | -124.80M | -127.94M | -126.04M |
| Income Before Tax | -116.91M | -112.46M | -118.09M | -120.23M | -117.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -116.91 | -112.46 | -118.09 | -120.23 | -117.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -116.91M | -112.46M | -118.09M | -120.23M | -117.86M |
| EBIT | -121.19M | -118.00M | -124.80M | -127.94M | -126.04M |
| EBITDA | -117.66M | -114.44M | -121.20M | -124.34M | -122.54M |
| EPS Basic | -1.70 | -1.65 | -1.74 | -1.78 | -1.75 |
| Normalized Basic EPS | -1.06 | -1.03 | -1.09 | -1.11 | -1.10 |
| EPS Diluted | -1.70 | -1.65 | -1.74 | -1.78 | -1.75 |
| Normalized Diluted EPS | -1.06 | -1.03 | -1.09 | -1.11 | -1.10 |
| Average Basic Shares Outstanding | 274.82M | 272.64M | 271.78M | 270.51M | 268.75M |
| Average Diluted Shares Outstanding | 274.82M | 272.64M | 271.78M | 270.51M | 268.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
